Organovo Holdings Inc. is a 3D bioprinting technology company specializing in the design and creation of functional human tissues for use in medical research and therapeutic applications. The company also develops and markets the platform technology for 3D bioprinting systems, and is currently pursuing the technology required to replicate entire human organs for transplant. Organovo was founded in 2007, employs 116 workers and is headquartered in San Diego, California, U.S.